United States· US:51662-1407_101e2af0-c51e-edc4-e063-6394a90a8b8c
(CHLOROPROCAINE HCI
A medicinal product containing chloroprocaine hydrochloride, registered in United States by HF Acquisition Co LLC, DBA HealthFirst.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHLOROPROCAINE HYDROCHLORIDE
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1151662-1407-1
- ndc11516621407130 mL in 1 VIAL, MULTI-DOSE (51662-1407-1)
- ndc11516621407325 POUCH in 1 CASE (51662-1407-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1407-2) / 30 mL in 1 VIAL, MULTI-DOSE
- ndc1151662-1407-3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chloroprocaine hydrochloride in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAmpres 10 mg/ml, soluzione iniettabileSintetica SA
- GermanyAmpresSintetica Gmbh
- BelgiumAmpres 10 mg/mlNordic Group
- SpainAMPRES 10 MG/ML SOLUCION INYECTABLEB Braun Medical S.A.
- FinlandAmpresB. Braun Melsungen AG
- United KingdomAmpres 400mg/20ml solution for injection vialsB.Braun Medical Ltd
- IrelandAmpres 10mg/ml solution for injectionB. Braun Melsungen AG
- SwedenAmpres 10 mg/ml Injektionsvätska, lösningB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Ampres, Visiclor
- Belgium · Ampres
- Bulgaria · Ампрес
- Germany · Ampres, Decelex
- Denmark · Ampres
- Estonia · Clorotekal
- Spain · Ampres
- Finland · Ampres
- France · Clorotekal
- United Kingdom (Northern Ireland) · Ampres
- Greece · Ampres
- Croatia · Clorotekal
- Hungary · Clorotekal
- Italy · Decelex
- Luxembourg · Ampres
- Latvia · Clorotekal
- Netherlands · Ampres
- Norway · Ampres
- Poland · Ampres
- Portugal · Ampres
- Sweden · Ampres
- Slovenia · Decelex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6d674209-54d1-49db-8cd2-401a9bf19480 GET /v1/drugs/6d674209-54d1-49db-8cd2-401a9bf19480?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INFILTRATION; PERINEURAL",
"source": "ndc",
"strength": "10",
"substance": "CHLOROPROCAINE HYDROCHLORIDE",
"productndc": "51662-1407",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA009435",
"marketing_category": "NDA"
}See everything about chloroprocaine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.